Chang, B. S. & Lowenstein, D. H. Epilepsy. N. Engl. J. Med. 349, 1257–1266 (2003).

Article  PubMed  Google Scholar 

World Health Organization. Epilepsy. https://www.who.int/news-room/fact-sheets/detail/epilepsy (2023).

Banerjee, P. N., Filippi, D. & Hauser, W. A. The descriptive epidemiology of epilepsy—a review. Epilepsy Res. 85, 31–45 (2009).

Article  PubMed  PubMed Central  Google Scholar 

Löscher, W. & Klein, P. The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond. CNS Drugs 35, 935–963 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Buckley, K. & Kelly, R. B. Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells. J. Cell Biol. 100, 1284–1294 (1985).

Article  CAS  PubMed  Google Scholar 

Takamori, S. et al. Molecular anatomy of a trafficking organelle. Cell 127, 831–846 (2006).

Article  CAS  PubMed  Google Scholar 

Muglia, P. et al. Padsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approach. Brain Commun. 2, fcaa183 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Wood, M. et al. Pharmacological profile of the novel antiepileptic drug candidate padsevonil: interactions with synaptic vesicle 2 proteins and the GABAA receptor. J. Pharmacol. Exp. Ther. 372, 1–10 (2020).

Article  CAS  PubMed  Google Scholar 

Rademacher, M. et al. Efficacy and safety of adjunctive padsevonil in adults with drug‐resistant focal epilepsy: results from two double‐blind, randomized, placebo‐controlled trials. Epilepsia Open 7, 758 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Feany, M. B., Lee, S., Edwards, R. H. & Buckley, K. M. The synaptic vesicle protein SV2 is a novel type of transmembrane transporter. Cell 70, 861–867 (1992).

Article  CAS  PubMed  Google Scholar 

Bindra, P. S., Knowles, R. & Buckley, K. M. Conservation of the amino acid sequence of SV2, a transmembrane transporter in synaptic vesicles and endocrine cells. Gene 137, 299–302 (1993).

Article  CAS  PubMed  Google Scholar 

Bajjalieh, S. M., Peterson, K., Linial, M. & Scheller, R. H. Brain contains two forms of synaptic vesicle protein 2. Proc. Natl Acad. Sci. USA 90, 2150–2154 (1993).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schivell, A. E., Mochida, S., Kensel-Hammes, P., Custer, K. L. & Bajjalieh, S. M. SV2A and SV2C contain a unique synaptotagmin-binding site. Mol. Cell. Neurosci. 29, 56–64 (2005).

Article  CAS  PubMed  Google Scholar 

Schivell, A. E., Batchelor, R. H. & Bajjalieh, S. M. Isoform-specific, calcium-regulated interaction of the synaptic vesicle proteins SV2 and synaptotagmin. J. Biol. Chem. 271, 27770–27775 (1996).

Article  CAS  PubMed  Google Scholar 

Lazzell, D. R., Belizaire, R., Thakur, P., Sherry, D. M. & Janz, R. SV2B regulates synaptotagmin 1 by direct interaction. J. Biol. Chem. 279, 52124–52131 (2004).

Article  CAS  PubMed  Google Scholar 

Kaempf, N. et al. Overlapping functions of stonin 2 and SV2 in sorting of the calcium sensor synaptotagmin 1 to synaptic vesicles. Proc. Natl Acad. Sci. USA 112, 7297–7302 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harper, C. B. et al. An epilepsy-associated SV2A mutation disrupts synaptotagmin-1 expression and activity-dependent trafficking. J. Neurosci. 40, 4586–4595 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang, N. et al. Phosphorylation of synaptic vesicle protein 2A at Thr84 by casein kinase 1 family kinases controls the specific retrieval of synaptotagmin-1. J. Neurosci. 35, 2492–2507 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Voleti, R., Jaczynska, K. & Rizo, J. Ca2+-dependent release of synaptotagmin-1 from the SNARE complex on phosphatidylinositol 4,5-bisphosphate-containing membranes. eLife 9, e57154 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou, Q. et al. Architecture of the synaptotagmin–SNARE machinery for neuronal exocytosis. Nature 525, 62–67 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Südhof, T. C. A molecular machine for neurotransmitter release: synaptotagmin and beyond. Nat. Med. 19, 1227–1231 (2013).

Article  PubMed  Google Scholar 

Madeo, M., Kovács, A. D. & Pearce, D. A. The human synaptic vesicle protein, SV2A, functions as a galactose transporter in Saccharomyces cerevisiae. J. Biol. Chem. 289, 33066–33071 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ciruelas, K., Marcotulli, D. & Bajjalieh, S. M. Synaptic vesicle protein 2: a multi-faceted regulator of secretion. Semin. Cell Dev. Biol. 95, 130–141 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bajjalieh, S. M., Frantz, G. D., Weimann, J. M., McConnell, S. K. & Scheller, R. H. Differential expression of synaptic vesicle protein 2 (SV2) isoforms. J. Neurosci. 14, 5223–5235 (1994).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Janz, R., Goda, Y., Geppert, M., Missler, M. & Südhof, T. C. SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release. Neuron 24, 1003–1016 (1999).

Article  CAS  PubMed  Google Scholar 

Paulussen, I. et al. SV2B defines a subpopulation of synaptic vesicles. J. Mol. Cell Biol. https://doi.org/10.1093/jmcb/mjad054 (2023).

Dardou, D. et al. Distribution of SV2C mRNA and protein expression in the mouse brain with a particular emphasis on the basal ganglia system. Brain Res. 1367, 130–145 (2011).

Article  CAS  PubMed  Google Scholar 

Crèvecœur, J. et al. Expression of SV2 isoforms during rodent brain development. BMC Neurosci. 14, 87 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Crowder, K. M. et al. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc. Natl Acad. Sci. USA 96, 15268–15273 (1999).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Calame, D. G., Herman, I. & Riviello, J. J. A de novo heterozygous rare variant in SV2A causes epilepsy and levetiracetam-induced drug-resistant status epilepticus. Epilepsy Behav. Rep. 15, 100425 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Serajee, F. J. & Huq, A. M. Homozygous mutation in synaptic vesicle glycoprotein 2A gene results in intractable epilepsy, involuntary movements, microcephaly, and developmental and growth retardation. Pediatr. Neurol. 52, 642–646.e1 (2015).

Article  PubMed  Google Scholar 

Wang, D. et al. Levetiracetam-induced a new seizure type in a girl with a novel SV2A gene mutation. Clin. Neurol. Neurosurg. 181, 64–66 (2019).